Early diagnosis of cancer in primary care Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: General practices will primarily be recruited from Wales, topped up with practices from North West of England. We will recruit 8-10 practices from each of the seven Health Boards in Wales, and 8-10 from North West England; this conservative estimate is informed by feasibility study recruitment. Wales and North West England have similar regional demography; with higher deprivation and cancer rates compared with other UK areas ?(NWCR, 2021b, 2021a)?. If recruitment is challenging, we propose to extend the study into South West England. Networks and contacts established through the feasibility study will be maintained in order to maximise recruitment across Wales, and regional Clinical Research Network (CRN) teams will assist in recruiting the practices across all of the centres.
Exclusion criteria
Exclusion criteria: All practice types will be included
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Primary care interval (PCI - time between first presentation of potential cancer to primary care and referral to secondary care) data. Collected retrospectively by GP research staff or trained nurses, using a Case Report form, for the period 14 to 26 months post-randomisation. 2. Cost-effectiveness in terms of incremental cost per day reduction in PCI and budget impact, collected via health economics data collection sheets/diaries after each GP-educator training event and practice workshop | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Conversion rate: Collected retrospectively via a Case Report Form sent to the practice, to be completed by the practice manager or allocated staff member for the following intervals: The 12 months prior to randomisation, 2 to 14 months post randomisation 2. USC/2WW referral rate: Collected retrospectively via a Case Report Form sent to the practice, to be completed by the practice manager or allocated staff member for the following intervals: The 12 months prior to randomisation, 2 to 14 months post randomisation 3. Detection rate: Collected retrospectively via a Case Report Form sent to the practice, to be completed by the practice manager or allocated staff member for the following intervals: The 12 months prior to randomisation, 14 to 26 months post-randomisation 4. Cancer stage at diagnosis: Collected retrospectively by GP research staff or trained nurses using a Case Report Form for the following intervals: 14 to 26 months post-randomisation 5. Adherence to NICE NG12 guidelines ?(NICE, 2015)?: Guideline interval – the time between patient first meeting any criterion within the NICE NG12 guidelines for referral to diagnosis ?(Price et al., 2021)? collected retrospectively by GP research staff or trained nurses using a Case Report form for the period 14 to 26 months post-randomisation. 6. Factors that contribute to longer Primary Care Intervals for patients diagnosed with cancer: qualitative measures plus subgroup analysis, case note review data collected in summarised form by GP research staff or trained nurses for the period 14 to 26 months post-randomisation. 7. Patient and carer experiences of urgent referral: qualitative measures collected via qualitative interviews with patients and carers; stakeholder interviews will take place between 3 and 6 months, interviews with patients and carers will take place from month 10 8. Mechanisms and contextual factors that drive the implementation of the intervention: practice characteristics and demographics co | — |
Countries
England, United Kingdom, Wales